About Us
|
contact Us
|
Sitemap
Call us: +1-855-455-8662
|
Home
Business Solutions
Business Research Reports
Business Consulting
On-site Implementation & Training Programs
Industry Trackers
Subscription Solutions
Industry Reports
News
Press
Login
Register
Home
Market Research
Pigmentation Disorders Treatment Market Set to Reach US$ 12,313.2 Mn by 2032
Pigmentation Disorders Treatment Market By Treatment (Topical Drugs, Chemical Peels, Microdermabrasion, Phototherapy, Laser Therapy), By Disease (Melasma, Albinism, Vitiligo, Post-Inflammatory Hyperpigmentation, Others) - Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
06 Aug 2018
Format
Request Sample
Report Summary
Table of contents
list of tables
list of figures
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Pigmentation Disorders Treatment Market
2.2. Global Pigmentation Disorders Treatment Market, By Treatment, 2023 (US$ Million)
2.3. Global Pigmentation Disorders Treatment Market, By Disease, 2023 (US$ Million)
2.4. Global Pigmentation Disorders Treatment Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023
3. Pigmentation Disorders Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Pigmentation Disorders Treatment Market Vendors
3.2. Strategies Adopted by Pigmentation Disorders Treatment Market Vendors
3.3. Key Industry Strategies
4. Pigmentation Disorders Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Pigmentation Disorders Treatment Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Topical Drugs
5.3.2. Chemical Peels
5.3.3. Microdermabrasion
5.3.4. Phototherapy
5.3.5. Laser Therapy
6. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Melasma
6.3.2. Albinism
6.3.3. Vitiligo
6.3.4. Post-Inflammatory Hyperpigmentation
6.3.5. Others (Solar Lentigines, Acne Vulgaris, etc.)
7. North America Pigmentation Disorders Treatment Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
7.3. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
7.4.Pigmentation Disorders Treatment Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
7.4.1.1.2. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
7.4.1.2.2. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
7.4.1.3.2. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
8. UK and European Union Pigmentation Disorders Treatment Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
8.3. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
8.4.Pigmentation Disorders Treatment Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
8.4.1.1.2. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
8.4.1.2.2. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
8.4.1.3.2. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
8.4.1.4.2. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
8.4.1.5.2. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
8.4.1.6.2. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
9. Asia Pacific Pigmentation Disorders Treatment Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
9.3. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
9.4.Pigmentation Disorders Treatment Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
9.4.1.1.2. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
9.4.1.2.2. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
9.4.1.3.2. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
9.4.1.4.2. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
9.4.1.5.2. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
9.4.1.6.2. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
10. Latin America Pigmentation Disorders Treatment Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
10.3. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
10.4.Pigmentation Disorders Treatment Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
10.4.1.1.2. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
10.4.1.2.2. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
10.4.1.3.2. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
11. Middle East and Africa Pigmentation Disorders Treatment Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
11.3. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
11.4.Pigmentation Disorders Treatment Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
11.4.1.1.2. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
11.4.1.2.2. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Pigmentation Disorders Treatment Market: By Treatment, 2022-2032, USD (Million)
11.4.1.3.2. Pigmentation Disorders Treatment Market: By Disease, 2022-2032, USD (Million)
12. Company Profile
12.1. ALLERGAN PLC
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Bayer AG
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Galderma S.A.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. EpiPharm AG
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Pierre Fabre Laboratories
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. La Roche-Posay Laboratoire Pharmaceutique
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Obagi Cosmeceuticals LLC
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. RXi Pharmaceuticals Corporation
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. SkinCeuticals, Inc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Vivier Pharma, Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
Choose Licence Type
Single User Licence
$4500
Multi User license
$6500
Corporate license
$9000
Buy Now
Quick Contact
+1-855-455-8662
+91 77559-81103
sales@acutemarketreports.com
View Other Reports
Automotive
986
Chemicals and Materials
684
Consumer Goods
184
Energy
124
Food & Beverages
321
Medical Devices
178
Pharmaceutical & Healthcare
78
Technology
234